SENSEX 82841.7 (-0.42)

Nifty 50 25258.9 (-0.38)

Nifty Bank 56873.6 (-0.14)

Nifty IT 37766.4 (-1.59)

Nifty Midcap 100 58852.1 (-0.52)

Nifty Next 50 68439.35 (-0.12)

Nifty Pharma 22291.15 (0.97)

Nifty Smallcap 100 18854.05 (-0.54)

Indian Market
Nifty 50 48,450.45 +541.45 | 0.85%
Nifty 100 48,450.45 +541.45 | 0.85%
Sensex 48,450.45 +541.45 | 0.85%
Sensex 48,450.45 +541.45 | 0.85%
Global Market
Nifty 50 48,450.45 +541.45 | 0.85%
Nifty 100 48,450.45 +541.45 | 0.85%
Sensex 48,450.45 +541.45 | 0.85%
Sensex 48,450.45 +541.45 | 0.85%
News
  • Investment Services
  • Empower your investments with real-time data and personalized strategies. Join us at JustTrade and shape your
  • Investment Services
  • Empower your investments with real-time data and personalized strategies. Join us at JustTrade and shape your
  • Investment Services
  • Empower your investments with real-time data and personalized strategies. Join us at JustTrade and shape your
Suven Pharmaceuticals renamed as Cohance Lifesciences
(09:39, 08 May 2025)
Suven Pharmaceuticals announced that the Ministry of Corporate Affairs, Government of India (MCA), has approved change of name of the Company from 'Suven Pharmaceuticals' to 'Cohance Lifesciences', with effect from 07 May 2025. The change of name has been carried on pursuant to the Scheme of Amalgamation.

The transition to Cohance Lifesciences marks a pivotal moment in our commitment to better serve our customers and their end market. We are building a global CDMO that aims to enable innovation across a broad range of modalities, chemistries, and technologies, to advance solutions for a healthier world said Cohance Executive Chairman, Vivek Sharma.

Powered by Capital Market - Live News